Morningstar

Asahi Kasei Corp 3407

Stock XTKS Rating as of Oct 27, 2026

News

Asahi Kasei Strengthens Carbon Footprint Transparency for Acrylonitrile Production with Independent Third-Party Verification

Business Wire Oct 20, 2026, 12:30:00 PM
Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

Business Wire Oct 9, 2026, 10:41:00 PM
Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall Elements

Business Wire Oct 9, 2026, 12:30:00 PM
Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients

Business Wire Oct 8, 2026, 12:30:00 PM
Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei Therapeutics

Business Wire Sep 29, 2026, 12:30:00 PM
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

Business Wire Sep 15, 2026, 12:30:00 PM
Asahi Kasei Microdevices’ CZ39 and CZ3K Current Sensors Featured in Microchip Technology’s Machine Learning-Based Arc Fault Detection Reference Design

Business Wire Sep 8, 2026, 12:30:00 PM
Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company’s 40-Year North American Battery Separator Strategy

Business Wire Aug 26, 2026, 12:30:00 PM
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion Batteries

Business Wire Aug 20, 2026, 12:30:00 PM
Asahi Kasei’s Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic Incentives

Business Wire Aug 19, 2026, 12:30:00 PM
Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in China

Business Wire Aug 6, 2026, 12:30:00 PM
Asahi Kasei to Acquire Biopharma Firm Aicuris for $921 Million

Global News Select Feb 26, 2026, 8:41:00 AM

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.